FOLR2 and neoplasm: Nalio et al. demonstrated that FOLR2+ tissue-resident macrophages, present in both healthy mammary glands and breast tumours, localized in perivascular areas in the tumour stroma and responded to tumour progression by triggering CD8+ T-cell activation to enhance antitumour immunity [47].